EVOTEC AG | 25.29 / +1.77% |
Date/Time | 05/26 / 17:29 |
Chg. / Chg.(%) | 0.44 / +1.77% |
Bid | - |
Ask | - |
Open | 24.83 |
Previous Close | 24.85 |
High | 25.32 |
Low | 24.66 |
Volume [EUR] | 282,710.46 |
Volume [Units] | 11,336 |
Price fixings | 207 |
ISIN | DE0005664809 |
Security | EVT/D |
Exchange | Turquoise |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
TradeGate | 25.360 | ![]() |
1,425 |
Frankfurt | 25.3600 | ![]() |
35 |
Quotrix | 25.2500 | ![]() |
|
Lang & Schwa.. | 25.120 | ![]() |
|
gettex | 25.170 | ![]() |
|
Xetra | 25.260 | ![]() |
135,910 |
Cboe Europe .. | 25.29 | ![]() |
106,939 |
London Inter.. | 25.20 | 35,304 | |
Turquoise | 25.29 | ![]() |
11,336 |
Stuttgart | 25.170 | 745 | |
Nasdaq Other.. | 27.0900 | ![]() |
100 |
Vienna Globa.. | 25.27 | ![]() |
0 |
München | 24.960 | 0 | |
Düsseldorf | 25.160 | 0 | |
Hamburg | 25.170 | 0 | |
Berlin | 25.260 | 0 | |
Hannover | 25.170 | 0 | |
Cboe Europe .. | 24.94 | 1,726 | |
Cboe Europe .. | 24.94 | 474 | |
Bulgaria | 26.33 | ![]() |
30 |
EUREX | Options |
News
- Curexsys Appoints Christian Eckert as Chief Operating Officer
10/20/2021 / 10:00 - GlobeNewswire - Pasithea Therapeutics Corp. and Evotec SE Enter into Drug Development Agreement
10/11/2021 / 12:50 - GlobeNewswire - Awakn Life Sciences Initiates New Chemical Entity Development Program with Evotec as Research Partner and Addiction Expert, Prof. David Nutt, as Program Lead
04/27/2021 / 13:30 - Newsfile Corp - Chinook Therapeutics and Evotec Announce Strategic Collaboration to Discover and Develop Novel Precision Medicines for Chronic Kidney Diseases
03/01/2021 / 14:15 - GlobeNewswire - CENTOGENE and Evotec Expand Collaboration Into Gaucher Disease
08/20/2020 / 07:30 - GlobeNewswire